Pay in 4 interest-free payments of $46.03 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
and HRP conjugate are sequentially added to microwells pre-coated with a von Willebrand Factor Cleaving Protease (vWFCP) capture antibody
It can also reduce the expression of cytokine receptors
It is produced in the liver and contains two binding sites for Fe3+ ions
CD86 also exerts a negative regulatory role through its interaction with the CTLA-4 receptor on T-cells
Viability Dye Staining: Add Zombie Violet™ Fixable Viability Kit (423114) to each well (refer to the instruction manual for dosage)
Human IL8Ra ELISA Kit Drug Target Proteins and HRP conjugate are sequentiallyProduct Specification Usage Required experimental equipment: 1. Microplate reader (450nm) 2. High precision pipettes and pipette tips: 0. 5 10uL, 5 50uL, 20 200uL, 200 1000uL 3. 37C incubator 4. Distilled or deionized water Sample preparation and requirements: Tissue homogenization: Rinse the tissue with pre chilled PBS (0. 01M, pH 7. 4) to remove residual blood (lysed red blood cells in the homogenate will affect the measurement results). Weigh and
US$ 122.50
US$ 14.95
US$ 69.95